Atrial fibrillation, a type of heart arrhythmia, is a leading cause of stroke. Additionally, strokes may be associated with arrhythmia onset. However, such arrhythmias tend to resolve within a few ...
The American Journal of Managed Care: Atrial Arrhythmias Common in DMD, but More Data on Treatment Are Needed Cases of atrial arrhythmia in patients with Duchenne muscular dystrophy (DMD) are common but lack a standard solution, and more long-term data on the management of arrhythmias in DMD are needed. Atrial Arrhythmias Common in DMD, but More Data on Treatment Are Needed Atrial arrhythmias were found in 26% of patients with sickle cell disease (SCD), with a significant association with stroke history. Early detection and treatment of atrial arrhythmias may help ... Please provide your email address to receive an email when new articles are posted on .
arrhythmias and atrial fibrillation, Pulsed field ablation reduced atrial arrhythmia burden at 12 months in patients with atrial fibrillation. Those ... Milwaukee Journal Sentinel: NovaRhythm Obtains Global Rights from Sanofi for SAR-297871 to Advance Precision Atrial Fibrillation Therapy NovaRhythm Obtains Global Rights from Sanofi for SAR-297871 to Advance Precision Atrial Fibrillation Therapy Tyler Morning Telegraph: Christus Health among first for trial treatment of atrial fibrillation The American Journal of Managed Care: Common Comorbidities and Underdiagnosis Associated With Atrial Fibrillation Experts discuss the multifaceted management of atrial fibrillation, stressing the importance of addressing comorbid conditions alongside the arrhythmia itself, while highlighting the challenges of ... TCTMD: Extreme Heat Seems to Spark More Atrial Arrhythmias in IED Patients When the temperature outside rises, particularly above 100°F, it appears the risk of atrial arrhythmias among patients with cardiac implantable electronic devices also goes up, new data show. The ...
arrhythmias and atrial fibrillation, MarketWatch: HUYABIO International Presents Positive Clinical Results from HBI-3000, a Novel Multi-ion Channel Blocker for Acute Atrial Fibrillation HUYABIO International Presents Positive Clinical Results from HBI-3000, a Novel Multi-ion Channel Blocker for Acute Atrial Fibrillation
